U.S. Markets close in 3 hrs 17 mins

We don't yet have the technology to cure Alzheimer's, health-care investor says

Angelica LaVito

A long list of companies in the last decade fail to find a treatment for Alzheimer's, including Biogen earlier this year. Conde is speaking on a panel at CNBC's Healthy Returns conference in New York. Biotech companies don't yet have the technology or understanding of Alzheimer's to find a cure for the disease that plagues almost 5.8 million people in the U.S., Andreessen Horowitz general partner Jorge Conde said Tuesday at CNBC's Healthy Returns conference in New York.